SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-025876
Filing Date
2022-11-30
Accepted
2022-11-30 16:32:30
Documents
14
Period of Report
2022-11-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20221128.htm   iXBRL 8-K 58073
2 EX-99.1 rkda-ex99_1.htm EX-99.1 16413
3 GRAPHIC img192114479_0.jpg GRAPHIC 91856
  Complete submission text file 0000950170-22-025876.txt   321523

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20221128_lab.xml EX-101.LAB 13360
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20221128.xsd EX-101.SCH 2463
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20221128_pre.xml EX-101.PRE 9839
8 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20221128_htm.xml XML 4672
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 221435984
SIC: 0100 Agricultural Production-Crops